Reference
Xu J, et al. Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports. Medicine 100: No. 18, 7 May 2021. Available from: URL: http://doi.org/10.1097/MD.0000000000025784
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1864, 42 (2021). https://doi.org/10.1007/s40278-021-98972-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-98972-2